These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 36424137)

  • 1. Microenvironment-Based Diabetic Foot Ulcer Nanomedicine.
    Huang F; Lu X; Yang Y; Yang Y; Li Y; Kuai L; Li B; Dong H; Shi J
    Adv Sci (Weinh); 2023 Jan; 10(2):e2203308. PubMed ID: 36424137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanozymes for the Therapeutic Treatment of Diabetic Foot Ulcers.
    Xiao X; Zhao F; DuBois DB; Liu Q; Zhang YL; Yao Q; Zhang GJ; Chen S
    ACS Biomater Sci Eng; 2024 Jul; 10(7):4195-4226. PubMed ID: 38752382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-rich plasma for the treatment of diabetic foot ulcer: a systematic review.
    OuYang H; Tang Y; Yang F; Ren X; Yang J; Cao H; Yin Y
    Front Endocrinol (Lausanne); 2023; 14():1256081. PubMed ID: 38169990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Promising Hydrogel Candidates for Preclinically Treating Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis.
    Wu H; Ni R; Shi Y; Hu Y; Shen Z; Pang Q; Zhu Y
    Adv Wound Care (New Rochelle); 2023 Jan; 12(1):28-37. PubMed ID: 35229628
    [No Abstract]   [Full Text] [Related]  

  • 5. Thou shall not heal: Overcoming the non-healing behaviour of diabetic foot ulcers by engineering the inflammatory microenvironment.
    Monaghan MG; Borah R; Thomsen C; Browne S
    Adv Drug Deliv Rev; 2023 Dec; 203():115120. PubMed ID: 37884128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving beyond nanotechnology to uncover a glimmer of hope in diabetes medicine: Effective nanoparticle-based therapeutic strategies for the management and treatment of diabetic foot ulcers.
    Hosseinzadeh A; Zamani A; Johari HG; Vaez A; Golchin A; Tayebi L; Vafa E; Abbasi M; Amani AM; Chelliapan S; Kamyab H; Anbardar MH; Jangjou A
    Cell Biochem Funct; 2023 Jul; 41(5):517-541. PubMed ID: 37282756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Developing Immunocompetent Diabetic Foot Ulcer-on-a-Chip Models for Drug Testing.
    Ejiugwo M; Rochev Y; Gethin G; O'Connor G
    Tissue Eng Part C Methods; 2021 Feb; 27(2):77-88. PubMed ID: 33406980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biological therapies for the treatment of diabetic foot ulcers.
    Adeghate J; Nurulain S; Tekes K; Fehér E; Kalász H; Adeghate E
    Expert Opin Biol Ther; 2017 Aug; 17(8):979-987. PubMed ID: 28532226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers.
    Catrina SB; Zheng X
    Diabetes Metab Res Rev; 2016 Jan; 32 Suppl 1():179-85. PubMed ID: 26453314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive Glycemic Control for Diabetic Foot Ulcer Healing: A Multicentric, Randomized, Parallel Arm, Single-Blind, Controlled Study Protocol (INGLOBE Study).
    Rastogi A; Mukhopadhyay S; Sahoo JP; Mennon A; Ghosh A; Jha S; Bal A
    Int J Low Extrem Wounds; 2022 Dec; 21(4):443-449. PubMed ID: 32907433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular immunological mechanisms of impaired wound healing in diabetic foot ulcers (DFU), current therapeutic strategies and future directions.
    Mohsin F; Javaid S; Tariq M; Mustafa M
    Int Immunopharmacol; 2024 Sep; 139():112713. PubMed ID: 39047451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of Low Plasma Arginine among Patients with Diabetic Foot Ulcer (DFU).
    Hamad NA; Eltayeb LB; Yassin HM
    Pak J Biol Sci; 2024 Jan; 27(1):46-51. PubMed ID: 38413397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reappraising Diabetic Foot Ulcers: A Focus on Mechanisms of Ulceration and Clinical Evaluation.
    Aldana PC; Cartron AM; Khachemoune A
    Int J Low Extrem Wounds; 2022 Sep; 21(3):294-302. PubMed ID: 32734837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CXCL8 in chronic nonhealing diabetic foot ulcers and phenotypic changes in fibroblasts: a molecular perspective.
    Rai V; Moellmer R; Agrawal DK
    Mol Biol Rep; 2022 Feb; 49(2):1565-1572. PubMed ID: 35044539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose folic acid and its effect on early stage diabetic foot ulcer wound healing.
    Boykin JV; Hoke GD; Driscoll CR; Dharmaraj BS
    Wound Repair Regen; 2020 Jul; 28(4):517-525. PubMed ID: 32141182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects.
    Liu Y; Liu Y; Deng J; Li W; Nie X
    Front Endocrinol (Lausanne); 2021; 12():744868. PubMed ID: 34721299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D scaffolds in the treatment of diabetic foot ulcers: New trends vs conventional approaches.
    Glover K; Stratakos AC; Varadi A; Lamprou DA
    Int J Pharm; 2021 Apr; 599():120423. PubMed ID: 33647412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of foot ulcer tissue reveals novel potential therapeutic targets of wound healing in diabetic foot ulcers.
    Wang Y; Pi Y; Hu L; Peng Z; Hu H; Zhao J; Zhou Y; Wang D
    Comput Biol Med; 2023 Jun; 159():106858. PubMed ID: 37087778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of differential microbiomes in healing versus non-healing diabetic foot ulcers prior to and following foot salvage therapy.
    MacDonald A; Brodell JD; Daiss JL; Schwarz EM; Oh I
    J Orthop Res; 2019 Jul; 37(7):1596-1603. PubMed ID: 30908702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem and Somatic Cell Monotherapy for the Treatment of Diabetic Foot Ulcers: Review of Clinical Studies and Mechanisms of Action.
    Krasilnikova OA; Baranovskii DS; Lyundup AV; Shegay PV; Kaprin AD; Klabukov ID
    Stem Cell Rev Rep; 2022 Aug; 18(6):1974-1985. PubMed ID: 35476187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.